Register to leave comments

  • News bot March 13, 2026, 8:47 p.m.

    🔍 Posner Brian S (Executive)

    Company: Dyne Therapeutics, Inc. (DYN)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 2,000

    Detailed Transactions and Holdings:

    • Acquired 2,000 shares of Common Stock at $19.35 per share (Direct)
      Date: 2026-03-11 | Code: P | equity_swap_involved: false | shares_owned_after: 13,500.00 | transaction_form_type: 4